title: Delayed elimination of methotrexate associated with piperacillin administration.
authors.forename: K
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Sawada
authors.forename: Y
authors.initials: Y
authors.lastname: Matsushita
authors.forename: K
authors.initials: K
authors.lastname: Moriwaki
authors.forename: F
authors.initials: F
authors.lastname: Bessho
authors.forename: T
authors.initials: T
authors.lastname: Iga
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002648:Child; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D009503:Neutropenia / Q000188:drug therapy; D010878:Piperacillin / Q000009:adverse effects*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D010878:Piperacillin; D008727:Methotrexate